Ropivacaine
DrugLarge volume local anaesthetic intraarticularly
NCT Number: NCT03206554
40 patients ASA I-III, undergoing total knee arthroplasty were randomly assigned, into one of two groups, namely group LIA (n=20), where local infiltration analgesia would be administered intraoperatively; and group sham LIA (n=20), where sham injections of normal saline would be administered. All patients received a standardized multimodal approach, including pregabalin, adductor canal peripheral nervous blockade, spinal anaesthesia, paracetamol, and PCA with morphine. Morphine consumption during the first 24 hours postoperatively was measured and additionally the investigators recorded: Time of morphine first dose administration, NRS scores in static and dynamic conditions in 6 hours, 12 hours, 18 hours and 24 hours postoperatively, complications, patient satisfaction and duration of hospitalization.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Large volume local anaesthetic intraarticularly
sham injection
Time frame: 24 hours
Time frame: 24 hours
Time frame: 24 hours
Time frame: 24 hours
Patients asked whether they would choose the same anaesthetic management in a futue operaton: Yes / No
Time frame: 1 month
Number of days patients remain in the hospital postoperatively
Asklepieion Voulas General Hospital
Other Gov
Local Infiltration Analgesia in Total Knee Arthroplasty: A Randomized, Prospective, Placebo Controlled, Double Blinded Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05156476
Agnosia, Analgesia
Genk, Limburg, Belgium
View Trial DetailsNCT03942133
Agnosia, Analgesia
Beijing, China
View Trial DetailsNCT02799797
Agnosia, Analgesia
Beijing, Beijing Municipality, China
View Trial DetailsNCT06837844
Adductor Canal Block, Agnosia
Kafr ash Shaykh, Kafrelsheikh, Egypt
View Trial Details